Increasing wildfire activity in the US has made wildfire-specific fine particulate matter (PM 2.5 ) an important and growing source of air pollution, yet its long-term health impacts and relative toxicity compared with non-wildfire PM 2.5 remain unclear. Using a self-controlled design, we examine associations between 2-year average wildfire-specific and non-wildfire PM 2.5 and cardiopulmonary hospitalization risks across 20 US states during 2006–2019. Per 1 µg/m 3 increase, wildfire-specific PM 2.5 is associated with significantly higher hospitalization risks for all cardiopulmonary diseases, with relative risks ranging from 10% for heart failure to 16% for asthma. In contrast, a 1-µg/m 3 increase in non-wildfire PM 2.5 is associated with smaller risk elevations, ranging from 4.7% for chronic obstructive pulmonary disease to 8.5% for hypertension. Stronger associations for both wildfire-specific and non-wildfire PM 2.5 are observed among minorities, metropolitan residents, those with fewer years of education, and more deprived communities. Overall, at an equivalent concentration increase, long-term exposure to wildfire-specific PM 2.5 poses greater cardiopulmonary hospitalization risks than non-wildfire PM 2.5 , underscoring wildfire smoke as a growing public health threat that requires targeted mitigation alongside conventional air quality control strategies.
No takes yet. Share an insight, caveat, or question.
Zhang et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: